Mexico Approves First Domestic CAR-T Cell Trial for Leukemia

Mexico's health regulator Cofepris authorized the first clinical trial using domestically produced CAR-T cells for adult relapsed/refractory acute lymphoblastic leukemia. This marks a milestone in local advanced therapy development, though efficacy and safety data remain pending. It signals growing regional capacity in cell therapy manufacturing.